Victrelis

Showing 6 posts of 21 posts found.

Merck and Roche extend Victrelis co-promotion deal to Europe

July 22, 2011
Sales and Marketing Merck & Co, Roche, Victrelis, hepatitis C

Merck & Co is ramping up efforts to push its new hepatitis C treatment Victrelis to the fore, signing a …

MSD's Victrelis (boceprevir)

Hep C drug Victrelis gains EU approval

July 20, 2011
Sales and Marketing Incivek, Victrelis, hepatitis C

Merck Sharp & Dohme’s Victrelis, one of two major new hepatitis C drugs, has gained final approval in Europe. Victrelis …

Victrelis

Hepatitis C rivals go head to head

July 19, 2011
Sales and Marketing Incivek, Incivo, Victrelis, boceprevir, hepatitis C, telaprevir

 The field of hepatitis C treatment has two new groundbreaking medicines to treat the condition.Merck’s Victrelis (boceprevir) and Johnson & …

NICE to appraise hep C drugs Victrelis and telaprevir

May 26, 2011
Sales and Marketing Brinavess, Ilaris, NICE, Victrelis, Xarelto, Zytiga, telaprevir

NICE’s next round of drug appraisals is set to include two new hepatitis C drugs – Merck Sharpe and Dohme’s …

CHMP roundup

May 24, 2011
Sales and Marketing CHMP, EMA, Fampyra, Vibativ, Victrelis, Xgeva, Yervoy

The latest products to be recommended for European approval include MSD’s Victrelis, Astellas Pharma Europe’s Vibativ, Amgen Europe’s Xgeva and …

Merck & Co's Victrelis (boceprevir)

Merck’s hepatitis drug Victrelis approved by FDA

May 16, 2011
Sales and Marketing Merck & Co, Victrelis, boceprevir, hepatitis C

The FDA has approved Merck’s hepatitis C drug Victrelis, the first oral treatment for the disease. Victrelis (boceprevir) has been …

The Gateway to Local Adoption Series

Latest content